IRIS
IEZZI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.329
EU - Europa 715
AS - Asia 667
SA - Sud America 90
AF - Africa 7
OC - Oceania 1
Totale 2.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.312
SG - Singapore 261
CN - Cina 219
IE - Irlanda 127
IT - Italia 111
SE - Svezia 109
DE - Germania 93
FR - Francia 77
UA - Ucraina 73
TR - Turchia 71
BR - Brasile 69
GB - Regno Unito 49
VN - Vietnam 47
IN - India 32
AT - Austria 15
HK - Hong Kong 13
RU - Federazione Russa 13
FI - Finlandia 12
AR - Argentina 11
CZ - Repubblica Ceca 10
CA - Canada 8
MX - Messico 6
PL - Polonia 6
BD - Bangladesh 5
RO - Romania 5
BE - Belgio 4
JP - Giappone 4
LT - Lituania 4
IQ - Iraq 3
PY - Paraguay 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
CL - Cile 2
ES - Italia 2
KE - Kenya 2
PK - Pakistan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
MA - Marocco 1
NL - Olanda 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
Totale 2.809
Salva come PNG Salva come JPEG
Città #
Chandler 238
Singapore 209
Jacksonville 127
Dublin 126
Ashburn 107
Dearborn 90
Beijing 60
Dallas 58
Houston 58
Princeton 52
Munich 43
Los Angeles 42
Izmir 40
Nanjing 39
Wilmington 28
Altamura 26
Chieti 26
New York 24
The Dalles 24
Ann Arbor 21
Boardman 20
Dong Ket 20
Santa Clara 16
Southend 16
Cambridge 13
Ho Chi Minh City 13
Hong Kong 13
Kunming 13
Redondo Beach 12
São Paulo 12
Nanchang 10
Nuremberg 10
Washington 10
Brno 9
London 9
Pescara 9
Shenyang 9
Atlanta 8
Orem 8
Vienna 8
Jiaxing 7
Norwalk 7
Stockholm 7
Buffalo 6
Chicago 6
Denver 6
Hefei 6
Montreal 6
Tianjin 6
Brooklyn 5
Hebei 5
Helsinki 5
Warsaw 5
Brussels 4
Frankfurt am Main 4
Hyderabad 4
Mumbai 4
Tokyo 4
Tongling 4
Woodbridge 4
Zhengzhou 4
Boston 3
Chennai 3
Da Nang 3
Falls Church 3
Hangzhou 3
Istanbul 3
Johannesburg 3
Manchester 3
Mexico City 3
Perego 3
Phoenix 3
Poplar 3
Pune 3
Querétaro 3
San Francisco 3
Savigliano 3
Tappahannock 3
Tashkent 3
Asunción 2
Campinas 2
Cerveteri 2
Changsha 2
City of London 2
Elk Grove Village 2
Hanoi 2
Joinville 2
Lauterbourg 2
Leicester 2
Loreto Aprutino 2
Montevideo 2
Moscow 2
Palagiano 2
Rio de Janeiro 2
Rome 2
Secaucus 2
Turku 2
Vilnius 2
Addis Ababa 1
Alfredo Vasconcelos 1
Totale 1.879
Salva come PNG Salva come JPEG
Nome #
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 159
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 137
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 131
Trastuzumab Emtansine (T-DM1) in Patients (pts) With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC): results From a Multicenter Retrospective Analysis 128
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression 125
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 122
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 120
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 120
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 118
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 117
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer 115
Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting 112
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study 109
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial. 109
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag 107
Fulvestrant (FUL) 500 milligrams as endocrine therapy (ET) for hormone sensitive advanced breast cancer patients (pts). The Ful500 prospective observational trial 103
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience 102
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study 100
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 100
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage 97
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 97
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 97
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 97
Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. 96
Triple positive early breast cancer in the pre- and post Trastuzumab eras: a subgroup analysis of a multicenter retrospective study. 90
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting 73
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting 63
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 57
Totale 3.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.469
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 30 3 4 5 5 3 28
2021/2022142 0 6 0 33 6 4 6 8 9 4 15 51
2022/2023561 38 75 38 77 48 100 22 55 69 7 21 11
2023/2024268 31 13 17 11 19 99 38 5 6 10 3 16
2024/2025458 30 67 63 27 10 42 17 24 48 36 46 48
2025/2026587 99 42 109 161 157 19 0 0 0 0 0 0
Totale 3.001